Intravitreal injections used to treat a variety of ocular diseases may themselves contribute to progressive visual loss with chronic administration over years, according to researchers.
This article was reviewed by Jeffrey S. Heier, MD
Anti-VEGF injections are associated with acute IOP spikes and chronic IOP rise in patients, and these increases in IOP need to be acknowledged and managed, according to Matthew Schlenker MD, MSc, FRCPC.
This article was reviewed by Dr. Charles C. Wykoff, MD, PhD
This article was reviewed by Eric W. Schneider, MD
This article was reviewed by Chirag D. Jhaveri, MD
When used one week after injection, optical coherence tomography angiography can help clinicians determine how effective their treatment has been on neovascular membrane reperfusion.
Diabetic eye disease is occurring in younger populations, which means it's time to rethink anti-VEGF standards.